What is Bioptechs?
Bioptechs operates at the intersection of advanced microscopy and micro-environmental control, providing critical infrastructure for developmental biology, oncology, and cell biology research. The company's product portfolio, which includes sophisticated flow cell imaging chambers and objective heater systems, serves as a cornerstone for laboratories requiring precise environmental regulation during live-cell imaging. By bridging the gap between complex biological requirements and high-resolution imaging, Bioptechs has established itself as a vital partner for academic and commercial research institutions seeking to push the boundaries of cellular observation.
How much funding has Bioptechs raised?
Bioptechs has raised a total of $62K across 1 funding round:
Debt
$62K
Debt (2021): $62K with participation from PPP
Key Investors in Bioptechs
PPP
Public-Private Partnership
What's next for Bioptechs?
With the successful closure of this funding round, Bioptechs is poised to scale its manufacturing capabilities and expand its technical support infrastructure. The strategic deployment of this capital will likely focus on R&D initiatives aimed at refining their dish imaging systems and broadening their market reach into emerging oncology research sectors. As the demand for high-fidelity micro-environmental control continues to rise, the company is strategically aligned to capitalize on the growing need for reliable, high-performance laboratory instrumentation, ensuring sustained growth and long-term value creation for its stakeholders.
See full Bioptechs company page
